JW Pharmaceutical said Wednesday that Ertapenem, a carbapenem-based antibiotic using locally developed raw material, has landed in the U.S. market for the first time.In 2017, JW Holdings, the holding company of JW Pharmaceutical, signed a contract to export raw materials for ertapenem with Grand Pha
Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors have recently shown remarkable treatment outcomes in hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer.Although those drugs are increasingly used for earlier stages of breast cancer, each drug dem
Korean pharmaceutical companies developing drugs and diagnostics related to dementia enjoyed benefits from the recent U.S. Food and Drug Administration's approval of Biogen and Eisai's Alzheimer's disease treatment, aducanumab.For instance, PeopleBio, a company developing technology for early diagno
Daewoong Pharmaceutical said it has signed an agreement with Neurogastrx, a U.S. partner, to license out gastroesophageal reflux treatment, Fexuprazan,Under the accord, Neurogastrx will develop and license Fexuprazan in the U.S. and Canada. In addition, Daewoong will receive 5 percent of Neurogastrx
Daewoong Pharmaceutical said it completed the administration of Coviblock, an investigational oral Covid-19 drug, in a phase-2b trial on Friday.Coviblock is another name of Foister Tab. (camostat mesylate), a chronic pancreatitis treatment Daewoong is repurposing as an oral Covid-19 drug.Daewoong re
GC Pharma said it would drop its effort to commercialize GC5131, a plasma therapy candidate for the treatment of Covid-19.On Friday, GC Pharma said in a public filing that it would withdraw its application for a conditional nod for GC5131.On April 30, the company sought the Ministry of Food and Drug
Spectrum Pharmaceuticals, Hanmi Pharmaceutical’s U.S. partner, has been sued for infringing on the patent right of neutropenia treatment Rolontis (ingredient: eflapegrastim) by Bioverativ Therapeutics, Hanmi said Friday.Bioverativ filed a complaint against Spectrum with a U.S. district court on May
Local pharmaceutical companies, the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA), and the Korean Pharmaceutical Association (KPA) have rolled up their sleeves to promote local brands of acetaminophen-containing medicines.After the health authorities recommended taking antipy
Organon Korea said Thursday that Organon, a spinoff of Merck, has officially launched as a differentiated global healthcare company focusing on women’s health.Organon Korea, as a local offshoot of Organon, has prepared for the shift since February. “Based on market-leading products treating chronic
Icure Pharmaceutical recently obtained the Ministry of Food and Drug Safety’s nod to export patch-type donepezil, a treatment for Alzheimer’s disease.The export approval is expected to speed up the shipment of the patch to China in particular, as the company signed a deal to supply the product to Ch
Multinational pharmaceutical companies’ local offshoots are actively reducing workforce amid the prolonged Covid-19 pandemic, industry watchers said.In the first half of this year, the Korean branches of Viatris, GSK, Astellas, Zuellig Pharma, Janssen, and Roche, have announced the so-called early r
T&R Biofab, a company specializing in 3D bioprinting, said Thursday that it has signed a deal with Epibiotech, a new drug candidate material developer, to co-develop hair loss treatment using induced pluripotent stem cells.T&R Biofab and Epibiotech plan to establish a co-development system and promo
GSK said Wednesday that Trelegy Ellipta (ingredient: fluticasone furoate, umeclidinium, vilanterol), a triple inhaled therapy that reduces the mortality rate of chronic obstructive pulmonary disease (COPD) patients, has begun to receive insurance benefits from this month.At an online conference to c
Hanall Biopharma said Wednesday that Immunovant, its U.S. partner, has recently decided to resume the clinical trial of HL161, an autoimmune disease treatment.In February, Immunovant voluntarily suspended the clinical trials of HL161, known as IMVT-1401 in the U.S., due to an increase in cholesterol
Bridge Biotherapeutics said it began administering BBT-401, an ulcerative colitis drug candidate, to investigate the mechanism of action of a new method in clinical trials in New Zealand on Tuesday.The company aims to check the safety and efficacy of the new way of giving BBT-401 with six active ulc
The pharmaceutical industry is paying attention to whether Janssen’s Imbruvica (ingredient: ibrutinib) plus Abbvie's Venclexta (venetoclax) will become a new treatment option in blood cancer.At the American Society of Clinical Oncology (ASCO 2021) online meeting from Friday to Tuesday next week, com
The pace of the Covid-19 vaccination program is accelerating in Korea.Since late May, the health authorities allowed non-priority people to receive leftover Covid-19 vaccines, made available from canceled appointments or uses of low dead space syringes.Just in three months after the vaccination star
Pfizer Korea denied a media report on Tuesday concerning the Daegu Metropolitan Government’s push to introduce Pfizer's Covid-19 vaccine separately from the central government."Amid the Covid-19 pandemic, Pfizer is supplying its Covid-19 vaccines to only central governments and state regulators," a
Amgen has recently obtained the first-ever FDA approval for sotorasib (brand name: Lumakras), a treatment for KRAS G12-mutated non-small cell lung cancer (NSCLC).NSCLC with KRAS mutation has remained untreated for over 40 years.On Friday, the FDA approved the use of sotorasib, an oral KRAS G12C inhi
ST Pharm said it would develop the nation’s first lipid nanoparticle (LNP)-based Covid-19 mRNA vaccine that can respond to variant cases.In developing the vaccine, the company plans to apply Genevant Science's LNP technology, used in developing Pfizer and Moderna's mRNA vaccine, and its patented 5’-